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1 General Remarks 
 
1H NMR (300 MHz), 19F NMR (282 MHz) and 13C{1H} NMR (75 MHz) spectra were 
determined on a Bruker spectrometer. 1H NMR (400 MHz) and 13C{1H} NMR (100 
MHz) spectra were determined on a Bruker DPX400 spectrometer. COSY NMR spectra 
were determined on a Bruker AVII400 spectrometer. Chemical shifts (δ) are reported in 
parts per million (ppm) and calibrated to the residual solvent peak in DMSO-d6 (δ = 2.50 
(1H) and 39.51 ppm (13C)). The following abbreviations are used for spin multiplicity: s = 
singlet, d = doublet, dd = doublet of doublets, t = triplet, q = quartet, m = multiplet, br = 
broad. Infrared (IR) spectra were recorded on a Matterson Satellite (ATR) and are 
reported in wavenumbers (cm-1). High resolution electron spray (ES) mass spectra were 
recorded on a Bruker maXis ESI. All mass spectra are reported as m/z (relative intensity). 
Melting points were determined by a Barnstead Electrothermal 9100 melting point 
apparatus and were not corrected. Chloride concentrations during transport experiments 
were determined using an Accumet chloride-selective electrode. POPC (1-palmitoyl-2-
oleoyl-sn-glycero-3- phosphocholine) was supplied by Corden-Pharma and was stored at 
–20°C as a solution in chloroform (1 g POPC in 35 mL chloroform). 
Polyoxyethylene(8)lauryl ether was used as detergent (TCI).  
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2 Synthesis 
N-(hexylcarbamothioyl)benzamide 5 
 
Benzoyl isothiocyanate (0.20 g, 1.23 mmol) and hexylamine (0.123 g, 1.23 mmol) were 
dissolved in 1 mL ethyl acetate and stirred for 30 minutes. The solvent was removed 
under reduced pressure and the crude product was purified by column chromatography on 
silica (DCM) to give 5 as a colourless oil. 
Yield: 0.285 g (88 %); 1H NMR (300 MHz, DMSO-d6) δ = 11.27 (s, 1H, NH), 10.88 (t, J 
= 4.9 Hz, NH), 7.92 (m, 2H, Ar-CH), 7.63 (m, 1H, Ar-CH), 7.51 (m, 2H, Ar-CH), 3.60 
(m, 2H, CH2), 1.61 (m, 2H, CH2), 1.33 (m, 6H, 3 x CH2), 0.87 (m, 3H, CH3); 13C NMR 
(75 MHz, DMSO-d6): δ= 180.0 (C=S), 168.0 (C=O), 132.9, 132.2 128.5, 44.7, 30.9, 27.5, 
26.0, 22.0, 13.9; LRMS (ESI+) m/z: 264.1 [M + H]+; HRMS (ES+) m/z: [M + H]+ 
calculated 265.1375, found 265.1366; [M + Na]+ calculated 287.1194, found 287.1188. 
IR (film): ν= 3210, 2930, 2850, 1670 (C=O stretching), 1510 (C=S stretching). 
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Acyl thiourea synthesis: general procedure 
 
 
 
The acid chloride (5.5 mmol) was dissolved in 7.5 mL ethyl acetate and ammonium 
thiocyanate (0.494 g, 6.5 mmol) and PEG-400 (0.08 g) were added. The reaction was 
stirred for 1 h, after which an amine (5.5 mmol) was added and the reaction was stirred 
for a further 30 min. The inorganic solids were removed by filtration and the crude 
product (filtrate) was purified by column chromatography on silica (eluents detailed 
below). 
N-(hexylcarbamothioyl)-4-(trifluoromethyl)benzamide 6 
 
Purified by column chromatography on silica (DCM) to give the product as a white 
crystalline solid. 
Yield: 0.600 g (33 %); 1H NMR (300 MHz, DMSO-d6) δ = 11.56 (s, 1H, NH), 10.78 (t, J 
= 5.1 Hz, 1H, NH), 8.09 (d, J = 8.1 Hz, 2H, Ar-CH), 7.87 (d, J = 8.4 Hz, 2H, Ar-CH), 
3.61 (m, 2H, CH2), 1.61 (m, 2H, CH2), 1.33 (m, 6H, 3 x CH2), 0.87 (t, J = 6.6 Hz, 3H, 
CH3); 19F NMR (300 MHz, DMSO-d6) 61.28 (CF3); 13C NMR (75 MHz, DMSO-d6): δ= 
179.7 (C=S), 167.0 (C=O), 136.3, 132.3 (q, JC-F = 32.1 Hz, C-CF3), 129.5, 125.3, 123.8 
(q, JC-F = 272.6 Hz, CF3), 121.9, 118.3, 44.8, 30.9, 27.5, 26.1, 22.0; Mp: 58-60 °C; 
LRMS (ESI+) m/z: 333.2 [M + H]+, 355.3 [M + Na]+; HRMS (ES+) m/z: [M + H]+ 
calculated 333.1248, found 333.1229. IR (film): ν=3210, 2930, 2850, 1670 (carbonyl 
C=O stretching), 1534 (C=S stretching). 
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N-(hexylcarbamothioyl)-4-methoxybenzamide 7 
 
Purified by column chromatography on silica (DCM) to give the product as a colourless 
oil which formed a white crystalline solid on scratching. 
Yield: 0.820 g (51 %); 1H NMR (300 MHz, DMSO-d6) δ = 11.07 (s, 1H, NH), 10.95 (t, J 
= 5.1 Hz, 1H, NH), 7.96 (d, J = 8.8 Hz, 2H, Ar-CH), 7.03 (d, J = 9.1 Hz, 2H, Ar-CH), 
3.84 (s, 3H, OCH3), 3.59 (m, 2H, CH2), 1.60 (m, 2H, CH2), 1.29 (m, 6H, 3 x CH2), 0.87 (t, 
J = 6.6 Hz, CH3); 13C NMR (75 MHz, DMSO-d6): δ= 180.1 (C=S), 167.3 (C=O), 163.1, 
130.8, 124.0, 113.7, 55.6, 44.7, 30.9, 27.5, 26.0, 22.0, 13.9; Mp: 62-64 °C; LRMS 
(ESI+) m/z: 295.3 [M + H]+, 317.3 [M + Na]+; HRMS (ES+) m/z: [M + H]+ calculated 
295.1480, found 295.1472; [M + Na]+ calculated 317.1300, found 317.1294; IR (film): ν 
= 3340, 3210, 2960, 2930, 2850, 1650 (C=O stretching), 1600. 
N-(hexylcarbamothioyl)-4-pentylbenzamide 8 
 
Purified by column chromatography on silica (DCM/ hexane 1:1) to give the product as a 
colourless oil. 
Yield: 0.945 g (51 %); 1H NMR (300 MHz, DMSO-d6) δ = 11.14 (s, 1H, NH), 10.92 (t, J 
= 5.3 Hz, 1H, NH), 7.86 (d, J = 8.4 Hz, 2H, Ar-CH), 7.32 (d, J = 8.4 Hz, 2H, Ar-CH), 
3.59 (m, 2H, CH2), 2.63 (t, J = 7.7 Hz, 2H, aromatic adjascent CH2),  1.48 (m, 4H, 2 x 
CH2), 1.29 (m, 10H, 5 x CH2), 0.86 (m, 6H, 2 x CH3); 13C NMR (75 MHz, DMSO-d6): 
δ= 180.0 (C=S), 167.8 (C=O), 148.0, 129.6, 128.6, 128.3, 44.7, 35.0, 30.9, 30.2, 27.5, 
26.0, 22.0, 21.9, 13.9 (alkyl resonances overlapping); LRMS (ESI+) m/z: 335.1 [M + H]+, 
358.2 [M + Na]+; HRMS (ES+) m/z: [M + NH]+ calculated 335.2157, found 335.2150; 
[M + Na]+ calculated 357.1977, found 357.1971; IR (film): ν=3250, 2920, 2850, 1670 
(C=O stretching), 1570. 
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N-(dipropylcarbamothioyl)benzamide 9 
 
Benzoyl isothiocyanate (0.500 g, 5.5 mmol) was dissolved in 7 mL EtOAc and 
dipropylamine (0.310 g, 5.5 mmol) was added. The reaction was stirred at room 
temperature for 1 hour, after which the crude product was purified by column 
chromatography on silica (DCM) to give 9 as an off-white waxy solid. In the 
characterizing NMR spectra, the two propyl groups were found to be inequivalent. 
Yield: 0.650 g, 45 %; 1H NMR (300 MHz, DMSO-d6): δ= 10.58 (br. s, 1H, NH), 7.91 (m, 
2H, Ar-CH), 7.60 (m, 1H, Ar-CH), 7.50 (m, 2H, Ar-CH), 3.88 (t, J = 7.3 Hz, 2H, CH2), 
3.42 (t, J = 7.5 Hz, 2H, CH2), 1.75 (m, 2H, CH2), 1.63 (m, 2H, CH2), 0.94 (t, J = 7.3 Hz, 
3H, CH3), 0.80 (t, J = 7.3 Hz, 3H, CH3); 13C NMR (75 MHz, DMSO-d6): δ= 181.5 (C=S), 
163.8 (C=O), 133.0, 132.2, 128.4, 128.0, 54.3, 53,7, 21.2, 19.1, 11.1; Mp: 64-67 °C 
LRMS (ESI+) m/z: 265.2 [M + H]+, 287.1 [M + Na]+; HRMS (ES+) m/z: [M + H]+ 
calculated 265.1375, found 265.1369; [M + Na]+ calculated 287.1194, found 287.1192. 
IR (film): ν=3140, 2960, 2930, 2870, 1670 (C=O stretching), 1540. 
N-(hexylcarbamoyl)benzamide 10 
 
Benzoyl isocyanate (0.200 g, 1.35 mmol) was dissolved in 5 mL EtOAc and hexylamine 
(0.138 g, 1.35 mmol) was added. The reaction was stirred at room temperature for 1 hour 
and monitored by TLC. After 1 hour, the solvent was removed and the crude product was 
purified by column chromatography on silica (DCM) to give 10 as a white crystalline 
solid. 
Yield: 0.100 g, 30 %; 1H NMR (300 MHz, DMSO-d6) δ = 10.65 (s, 1H, NH), 8.66 (t, J = 
5.5 Hz, 1H, NH), 7.96 (m, 2H, Ar-CH), 7.61 (m, 1H, Ar-CH), 7.49 (m, 2H, Ar-CH), 3.22 
(q, J = 6.6 Hz, 2H, CH2), 1.49 (m, 2H, CH2), 1.30 (m, 6H, 3 x CH2), 0.87 (t, J = 6.59 Hz, 
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3H, CH3); 
13C NMR (75 MHz, DMSO-d6): δ= 168.2 (C=O), 153.5 (C=O), 132.7, 128.4, 128.1, (1 
alkyl C resonance underneath DMSO), 30.9, 29.1, 26.0, 22.0, 13.9; Mp: 88-90 °C LRMS 
(ESI+) m/z: 265.2 [M + H]+, 287.1 [M + Na]+; HRMS (ES+) m/z: [M + H]+ calculated 
249.1603, found 249.1593; [M + Na]+ calculated 271.1422, found 271.1417; IR (film): 
ν=3310, 2920, 2850, 1690 (C=O stretching), 1660 (C=O stretching). 
N-(hexylcarbamoyl)benzothioamide 11 
 
Thiobenzamide (0.500 g, 3.64 mmol) was dissolved in 10 mL MeCN and KOH (~200 
mg, pellets) was added. The solution was stirred for 20 min, after which hexyl 
isothiocyanate (0.463 g, 3.64 mmol) was added. The reaction was stirred for a further 30 
min, then diluted with 100 mL water and extracted with DCM. The organic phase was 
dried over MgSO4 and purified by column chromatography on silica (DCM/ hexane 3:1) 
to give the product as a yellow oil which formed a crystalline solid on standing. 
Yield: 0.670 g (70 %); 1H NMR (300 MHz, DMSO-d6) δ = 11.74 (s, 1H, NH), 9.26 (br. s, 
1H, NH), 7.67 (m, 2H, Ar-CH), 7.52 (m, 1H, Ar-CH), 7.41 (m, 2H, Ar-CH), 3.24 (m, 2H, 
CH2), 1.50 (m, 2H, CH2), 1.31 (m, 6H, 3 x CH2), 0.87 (t, J = 6.59 Hz, 3H, CH3); 13C 
NMR (75 MHz, DMSO-d6): δ= 153.0 (C=S), 141.9 (C=O), 131.4, 127.9, 127.5, (1 alkyl 
C under DMSO peak), 30.8, 28.7, 26.0, 22.0. 13.9; Mp: 48-50 °C LRMS (ESI+) m/z: 
265.2 [M + H]+, 287.1 [M + Na]+; HRMS (ES+) m/z: [M + H]+ calculated 265.1375, 
found 265.1366; [M + Na]+ calculated 287.1194, found 287.1193; IR (film): ν= 3110, 
3030, 2930, 2920, 2850, 1690 (C=O stretching), 1550. 
N-(hexylcarbamothioyl)benzothioamide 12 
 
Thiobenzamide (0.500 g, 3.64 mmol) was dissolved in 10 mL MeCN and KOH (~200 
mg, pellets) was added. The solution was stirred for 20 min, after which hexyl isocyanate 
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 9 
(0.521 g, 3.64 mmol) was added. The reaction was stirred for a further 30 min, then 
diluted with 100 mL water and extracted with DCM. The organic phase was dried over 
MgSO4 and purified by column chromatography on silica (DCM/ hexane 9:1) followed 
by preparatory TLC (DCM/ hexane 75:25) to give a viscous orange oil which formed a 
solid when under vacuum. The product was found to decompose during the purification 
process and therefore was not isolated cleanly (a 1H NMR spectrum can be seen below). 
The product was found to further degrade over time to give a strong smell of hydrogen 
sulfide accompanied by a blackening of the oil and the growth of crystals of elemental 
sulfur (S8). 
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3 NMR Spectra (recorded in DMSO-d6) 
 
Fig. S1 The 1H NMR spectrum of receptor 5. 
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Fig. S2 The 13C NMR spectrum of receptor 5. 
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Fig. S3 The 1H NMR spectrum of receptor 6. 
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Fig. S4 The 13C NMR spectrum of receptor 6. 
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Fig. S5 The 19F NMR spectrum of receptor 6. 
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Fig. S6 The 1H NMR spectrum of receptor 7. 
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Fig. S7 The 13C NMR spectrum of receptor 7. 
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Fig. S8 The 1H NMR spectrum of receptor 8. 
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Fig. S9 The 13C NMR spectrum of receptor 8. 
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Fig. S10 The 1H NMR spectrum of receptor 9. 
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Fig. S11 The 13C NMR spectrum of receptor 9. 
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Fig. S12 The 1H NMR spectrum of receptor 10. 
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Fig. S13 The 13C NMR spectrum of receptor 10. 
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Fig. S14 The 1H NMR spectrum of receptor 11. 
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Fig. S15 The 13C NMR spectrum of receptor 11. 
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Fig. S16 The 1H NMR spectrum of receptor 12. Peaks marked are thought to be 
associated with the desired receptor, peaks marked    are impurities, some of which only 
appeared during attempted purification.  
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4 COSY NMR spectra 
 
Fig. S17 COSY NMR spectrum of receptor 5 in CDCl3  
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Fig. S18 COSY NMR spectrum of receptor 6 in CDCl3 
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Fig. S19 COSY NMR spectrum of receptor 7 in CDCl3  
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Fig. S20 COSY NMR spectrum of receptor 8 in CDCl3 
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Fig. S21 COSY NMR spectrum of receptor 11 in CDCl3. 
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Fig. S22 COSY NMR spectrum of receptor 11 in DMSO-d6. 
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F1 - Acquisition parameters
TD                  256
SFO1           400.1325 MHz
FIDRES        19.728535 Hz
SW               12.622 ppm
FnMODE               QF
F2 - Processing parameters
SI                 1024
SF          400.1300021 MHz
WDW                SINE
SSB      0
LB       0 Hz
GB       0
PC                 1.40
F1 - Processing parameters
SI                 1024
MC2                  QF
SF          400.1300030 MHz
WDW                SINE
SSB      0
LB       0 Hz
GB       0
S,O 10 mM (DMSO)
AVII400 [1]
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5 Single Crystal X-ray Diffraction 
Data were collected at the University of Southampton on a Rigaku AFC12 goniometer equipped 
with an enhanced sensitivity (HG) Saturn724+ detector mounted at the window of an FR-E+ 
SuperBright molybdenum rotating anode generator with VHF Varimax optics (70 µm focus). Cell 
determination, data collection, data reduction and cell refinement and  absorption correction were 
performed using CrystalClear-SM Expert 2.0 r7 (Rigaku, 2011). The structures were solved using 
SHELXS-97 (G. M. Sheldrick, Acta Cryst. (2008) A64 112-122) and refined on F2 by the full-
matrix least-squares technique using the SHELXL-97 program package (G. M. Sheldrick (1997), 
University of Göttingen, Germany). Graphics are generated using ORTEP-III, MERCURY 3.0 or 
ViewerLite and Pov-Ray. In all cases the non-hydrogen atoms are refined anisotropically till 
convergence. Hydrogen atoms were stereochemically fixed at idealized positions and then refined 
isotropically. Hydrogen bonds are calculated using HTAB command in SHELXL-97. Structures 
were deposited with the Cambridge Crystallographic Database Centre (CCDC) and given the 
numbers CCDC 941594-941597. 
X-ray data for compound 6, CCDC 941595 
Single crystals suitable for X-ray diffraction were obtained by slow evaporation of a solution of 
compound 6 in DCM. Crystal data for compound 6: C15H19F3N2OS, Mr = 332.39 g/mol, crystal 
size = 0.26 x 0.06 x 0.01 mm³, colourless plate, triclinic, space group P-1, a = 9.6713(7) Å, b = 
12.2170(9) Å, c = 14.0933(11) Å, α = 95.844(7) º, β = 92.324(7) º, γ = 104.975(7) º, V = 
1596.4(2) Å3, Z = 4, ρc = 1.383 g cm-3, µ = 0.236 mm-1, radiation and wavelength = MoK\a 
(0.71075), T = 100(2) K, θmax = 27.48, reflections collected: 14983, independent reflections: 7217 
(Rint = 0.0383), 397 parameters, R indices (all data): R1 = 0.0626, wR2 = 0.1175, final R indices [I 
> 2σI]: R1 = 0.0435, wR2 = 0.1086, GOOF = 1.039, largest diff. peak and hole = 0.324 and -0.404 
e Å³. 
 
Table S1. Hydrogen bond properties for 6 
Donor--H···Acceptor D-H (Å) H···A (Å) D···A (Å) D-H···A (°) 
N1-H1···S1 0.88 2.61 3.4905(14) 176.4 
N4-H4A···O2 0.88 1.92 2.6194(17) 134.8 
N2-H2···O1 0.88 1.93 2.6204(17) 134.4 
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Figure S23. ORTEP diagram of 6 with atom numbering, showing 50% probability factor for the thermal ellipsoids. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S24. Schematic representation of the intermolecular hydrogen bonds in the crystal of 6 (two different views (a) 
and (b)). For clarity, only atoms involved in hydrogen bonding are labeled. Hydrogen bonds are represented by dashed 
lines. 
 
(a)                                                                  (b) 
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X-ray data for compound 7, CCDC 941596 
Single crystals suitable for X-ray diffraction were obtained by slow evaporation of a solution of 
compound 7 in DCM. Crystal data for compound 7: C15H22N2O2S, Mr = 294.41 g/mol, crystal size 
= 0.06 x 0.04 x 0.01 mm³, colourless chip, monoclinic, space group P21/c, a = 18.395(8) Å, b = 
8.682(4) Å, c = 9.855(5) Å, α = 90 º, β = 98.783(6) º, γ = 90 º, V = 1555.4(12) Å3, Z = 4, ρc = 
1.257 g cm-3, µ = 0.212 mm-1, radiation and wavelength = MoK\a (0.71075), T = 100(2) K, θmax = 
25.34, reflections collected: 9085, independent reflections: 2842 (Rint = 0.1258), 196 parameters, 
R indices (all data): R1 = 0.0810, wR2 = 0.1388, final R indices [I > 2σI]: R1 = 0.0614, wR2 = 
0.1513, GOOF = 1.003, largest diff. peak and hole = 0.340 and -0.271 e Å³. The hexyl chain was 
found to be disorder and was modeled with 2 separate orientations. 
 
Table S2. Hydrogen bond properties for 7 
Donor--H···Acceptor D-H (Å) H···A (Å) D···A (Å) D-H···A (°) 
N1-H1···O1 0.88 2.28 3.116(3) 159.4 
N2-H2A···O1 0.88 2.00 2.678(3) 133.4 
N2-H2A···S1 0.88 2.77 3.431(3) 133.1 
 
 
 
Figure S25. ORTEP diagram of 7 with atom numbering, showing 50% probability factor for the thermal ellipsoids. 
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Figure S26. Schematic representation of the intermolecular hydrogen bonds in the crystal of 7. For clarity, only atoms 
involved in hydrogen bonding are labeled. Hydrogen bonds are represented by dashed lines. 
X-ray data for compound 10, CCDC 941597 
Single crystals suitable for X-ray diffraction were obtained by slow evaporation of a solution of 
compound 10 in DCM. Crystal data for compound 10: C14H20N2O2, Mr = 248.32 g/mol, crystal 
size = 0.20 x 0.06 x 0.02 mm³, colourless lath, monoclinic, space group P21/c, a = 5.166(3) Å, b 
= 34.07(2) Å, c = 7.566(5) Å, α = 90 º, β = 101.193(10) º, γ = 90 º, V = 1306.3(14)) Å3, Z = 4, ρc 
= 1.263 g cm-3, µ = 0.085 mm-1, radiation and wavelength = MoK\a (0.71075), T = 100(2) K, θmax 
= 25.02, reflections collected: 4606, independent reflections: 2078 (Rint = 0.0389), 164 
parameters, R indices (all data): R1 = 0.0708, wR2 = 0.1083, final R indices [I > 2σI]: R1 = 0.0510, 
wR2 = 0.0988, GOOF = 1.038, largest diff. peak and hole = 0.193 and -0.194 e Å³.  
 
Table S3. Hydrogen bond properties for 10 
Donor--H···Acceptor D-H (Å) H···A (Å) D···A (Å) D-H···A (°) 
N1-H1···O1 0.88 2.21 3.029(3) 153.8 
N2-H2···O1 0.88 2.08 2.730(2) 129.7 
N2-H2···O2 0.88 2.33 2.941(3) 126.4 
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Figure S27. ORTEP diagram of 10 with atom numbering, showing 50 % probability factor for the thermal ellipsoids. 
 
 
Figure S28. Schematic representation of the intermolecular hydrogen bonds in the crystal of 10. For clarity, only atoms 
involved in hydrogen bonding are labeled and disorder is omitted. Hydrogen bonds are represented by dashed lines. 
X-ray data for compound 11, CCDC 941594 
Single crystals suitable for X-ray diffraction were obtained by slow evaporation of a solution of 
compound 11 in 3:1 DCM:hexane. Crystal data for compound 11: C14H20N2OS, Mr = 264.38 
g/mol, crystal size = 0.55 x 0.04 x 0.01 mm³, yellow needle, monoclinic, space group P21/c, a = 
3.9805(12) Å, b = 21.132(7) Å, c = 16.710(5) Å, α = 90 º, β = 96.391(4) º, γ = 90 º, V = 1396.8(8) 
Å3, Z = 4, ρc = 1.257 g cm-3, µ = 0.223 mm-1, radiation and wavelength = MoK\a (0.71075), T = 
100(2) K, θmax = 27.52, reflections collected: 6301, independent reflections: 3169 (Rint = 0.0185), 
163 parameters, R indices (all data): R1 = 0.0459, wR2 = 0.0871, final R indices [I > 2σI]: R1 = 
0.0393, wR2 = 0.0834, GOOF = 1.072, largest diff. peak and hole = 0.354 and -0.232 e Å³.  
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Table S4. Hydrogen bond properties for 11 
Donor--
H···Acceptor 
D-H (Å) H···A (Å) D···A (Å) D-H···A (°) 
N2-H2···S1 0.88 2.28 3.0046(15) 140.2 
N1-H1···O1 0.88 2.01 2.8672(15) 166.0 
 
 
 
Figure S29. ORTEP diagram of 11 with atom numbering, showing 50 % probability factor for the thermal ellipsoids. 
 
 
Figure S30. Schematic representation of the intermolecular hydrogen bonds in the crystal of 11. For clarity, only atoms 
involved in hydrogen bonding are labeled and disorder is omitted. Hydrogen bonds are represented by dashed lines. 
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6 D2O shake experiments (5 mL of 0.01 M receptor in DMSO-d6) 
 
Fig. S31 Changes to the aromatic region of the 1H NMR spectrum of receptor 6 in 
DMSO-d6 (0.01 M) upon the addition of D2O (absolute intensity). 
 
Fig. S32 Changes to the aromatic region of the 1H NMR spectrum of receptor 6 in 
DMSO-d6/ 1 % H2O (0.01 M) upon the addition of D2O (absolute intensity). 
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Fig. S33 Changes to the aromatic region of the 1H NMR spectrum of receptor 7 in 
DMSO-d6 (0.01 M) upon the addition of D2O (absolute intensity). 
 
Fig. S34 Changes to the aromatic region of the 1H NMR spectrum of receptor 7 in 
DMSO-d6/ 1 % H2O (0.01 M) upon the addition of D2O (absolute intensity). 
 40 
 
 
 
Fig. S35 Changes to the aromatic region of the 1H NMR spectrum of receptor 8 in 
DMSO-d6 (0.01 M) upon the addition of D2O (absolute intensity). 
 
Fig. S36 Changes to the aromatic region of the 1H NMR spectrum of receptor 8 in 
DMSO-d6/ 1 % H2O (0.01 M) upon the addition of D2O (absolute intensity). 
 41 
 
 
Fig. S37 Changes to the aromatic region of the 1H NMR spectrum of receptor 10 in 
DMSO-d6 (0.01 M) upon the addition of D2O (absolute intensity). 
 
Fig. S38 Changes to the aromatic region of the 1H NMR spectrum of receptor 13 in 
DMSO-d6/ 1 % H2O (0.01 M) upon the addition of D2O (absolute intensity). 
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Fig. S39 Changes to the aromatic region of the 1H NMR spectrum of receptor 11 in 
DMSO-d6 (0.01 M) upon the addition of D2O (absolute intensity). 
 
Fig. S40 Changes to the aromatic region of the 1H NMR spectrum of receptor 11 in 
DMSO-d6/ 1 % H2O (0.01 M) upon the addition of D2O (absolute intensity). 
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7 Anion transport experiments 
7.1 Preparation of vesicles 
A lipid film of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 
cholesterol (0% or 30%) was formed from a chloroform solution under reduced pressure 
and dried under vacuum for at least 4 hours. The lipid film was rehydrated by vortexing 
with a metal chloride (MCl) salt solution (489 mM MCl, 5 mM phosphate buffer at pH 
7.2). The lipid suspension was then subjected to seven freeze-thaw cycles and allowed to 
age for 30 min at room temperature before extruding 25 times through a 200 nm 
polycarbonate membrane. The resulting unilamellar vesicles were dialyzed against the 
external medium to remove unencapsulated MCl salts. 
7.2 Cl-/NO3- antiport assays 
Unilamellar POPC vesicles containing NaCl, prepared as described above, were 
suspended in 489 mM NaNO3 buffered to pH 7.2 with sodium phosphate salts. The lipid 
concentration per sample was 1 mM. A DMSO solution of the carrier molecule (10 mM) 
was added to start the experiment and the chloride efflux was monitored using a chloride 
selective electrode. At 5 min, the vesicles were lysed with 50 µl of 
polyoxyethylene(8)lauryl ether (0.232 mM in 7:1 water:DMSO v/v) and a total chloride 
reading was taken at 7 min. 
7.3 Cl-/HCO3- antiport assays  
Unilamellar POPC vesicles containing 489 mM NaCl solution buffered to pH 7.2 with 20 
mM sodium phosphate salts, prepared as described above, were suspended in the external 
medium consisting of a 162 mM Na2SO4 solution buffered to pH 7.2 with sodium 
phosphate salts (20 mM buffer). The lipid concentration per sample was 1 mM. A DMSO 
solution of the carrier molecule (10 mM) was added to start the experiment and chloride 
efflux was monitored using a chloride sensitive electrode. At 2 min, a NaHCO3 solution 
(1.2 M in 162 mM Na2SO4 buffered to pH 7.2 with 20 mM sodium phosphate salts) was 
added so that the outer solution contained 40 mM NaHCO3. At 7 min, the vesicles were 
lysed with 50 µl of polyoxyethylene(8)lauryl ether (0.232 mM in 7:1 water:DMSO v/v) 
and a total chloride reading was taken at 9 min. 
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7.4 Hill plots 
During the Hill plots the chloride/nitrate transport assays were performed as described 
above (see section 6.1) for various concentrations of carrier. The chloride efflux (%) 270 
s after the addition of carrier was plotted as a function of the carrier concentration. Data 
points were fitted to the Hill equation using Origin 8.1: 
𝑦 = 𝑉!"# 𝑥!𝑘! + 𝑥! 
where y is the chloride efflux at 270 s (%) and x is the carrier concentration (mol% 
carrier to lipid). Vmax, k and n are the parameters to be fitted. Vmax is the maximum 
efflux possible (this was fixed to 100%, as this is physically the maximum chloride efflux 
possible), n is the Hill coefficient and k is the carrier concentration needed to reach 
Vmax/2 (when Vmax is fixed to 100%, k equals EC50). From the Hill plot it is therefore 
possible to directly obtain EC50,270s values, defined as the carrier concentration (molar % 
carrier to lipid) needed to obtain 50 % chloride efflux after 270 s. To ensure repeatability 
and precise data, each Cl-/NO3- Hill plot was repeated a minimum of 3 times and was 
conducted each time with a newly prepared set of vesicles. 
 
 
Fig. S41 Hill plot (repeat 1) for Cl-/NO3- antiport by receptor 5. EC50, 270 s = 0.39 mol%, n 
= 2.4. 
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Fig. S42 Hill plot (repeat 2) for Cl-/NO3- antiport by receptor 5. EC50, 270 s = 0.30 mol%, n 
= 2.1. 
 
 
Fig. S43 Hill plot (repeat 3) for Cl-/NO3- antiport by receptor 5. EC50, 270 s = 0.29 mol%, n 
= 1.8. 
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Fig. S44 Hill plot (repeat 1) for Cl-/NO3- antiport by receptor 6. EC50, 270 s = 0.69 mol%, 
n = 3.0. 
 
Fig. S45 Hill plot (repeat 2) for Cl-/NO3- antiport by receptor 6. EC50, 270 s = 0.69 mol%, 
n = 2.8. 
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Fig. S46 Hill plot (repeat 3) for Cl-/NO3- antiport by receptor 6. EC50, 270 s = 0.70 mol%, 
n = 2.5. 
 
Fig. S47 Hill plot (repeat 1) for Cl-/NO3- antiport by receptor 7. EC50, 270 s = 0.30 mol%, 
n = 2.1. 
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Fig. S48 Hill plot (repeat 2) for Cl-/NO3- antiport by receptor 7. EC50, 270 s = 0.27 mol%, 
n = 2.1. 
 
Fig. S49 Hill plot (repeat 3) for Cl-/NO3- antiport by receptor 7. EC50, 270 s = 0.26 mol%, 
n = 1.9.  
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Fig. S50 Hill plot (repeat 1) for Cl-/NO3- antiport by receptor 8. EC50, 270 s = 0.93 mol%, 
n = 2.2. NB All carrier concentrations were added using varying volumes of a 5 mM 
solution of the receptor in DMSO. 
 
Fig. S51 Hill plot (repeat 2) for Cl-/NO3- antiport by receptor 8. EC50, 270 s = 1.1 mol%, 
n = 2.5. NB All carrier concentrations were added using varying volumes of a 5 mM 
solution of the receptor in DMSO. 
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Fig. S52 Hill plot (repeat 3) for Cl-/NO3- antiport by receptor 8. EC50, 270 s = 1.2 mol%, 
n = 2.1. NB All carrier concentrations were added using varying volumes of a 5 mM 
solution of the receptor in DMSO. 
 
Fig. S53 Hill plot for Cl-/HCO3- antiport by receptor 3. EC50, 390 s = 5.8 mol%, n = 0.73. 
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Fig. S54 Hill plot for Cl-/HCO3- antiport by receptor 4. EC50, 390 s = 0.10 mol%, n = 1.5. 
 
 
 
Fig. S55 Hill plot for Cl-/HCO3- antiport by receptor 5. EC50, 390 s = 0.27 mol%, n = 0.78. 
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Fig. S56 Hill plot for Cl-/HCO3- antiport by receptor 6. Vmax was fixed at 55 %. 
Calculated EC50, 390 s = 8.1 mol%, n = 0.77. 
 
Fig. S57 Hill plot for Cl-/HCO3- antiport by receptor 7. EC50, 390 s = 0.28 mol%, n = 0.91. 
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Fig. S58 Hill plot for Cl-/HCO3- antiport by receptor 8. EC50, 390 s = 6.5 mol%, n = 1.46. 
 
7.5 M+/Cl- symport assays 
Unilamellar POPC vesicles containing NaCl or CsCl, prepared as described above, were 
suspended in 167 mM NaNO3 buffered to pH 7.2 with sodium phosphate salts. The lipid 
concentration per sample was 1 mM. A DMSO solution of the carrier molecule (10 mM) 
was added to start the experiment and the chloride efflux was monitored using a chloride 
selective electrode. At 5 min, the vesicles were lysed with 50 µl of 
polyoxyethylene(8)lauryl ether (0.232 mM in 7:1 water:DMSO v/v) and a total chloride 
reading was taken at 7 min. 
 
Fig. S59 Chloride release mediated by receptors 5-8 (2 mol% w.r.t. lipid) from POPC 
vesicles containing NaCl (left) or CsCl (right) suspended in Na2SO4. 
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7.6 Cholesterol assays 
In order to probe the effect of modifying the membrane viscosity on anion transport 
activity, the Cl-/NO3- antiport assay was repeated for receptors 5-8 in vesicles composed 
of POPC/cholesterol (7:3). The chloride efflux after 270 s in both POPC and 
POPC/cholesterol vesicles is shown below. 
 
Fig. S60 Chloride efflux (Cl-/NO3- antiport) mediated by receptors 5-8 from vesicles 
composed of POPC and POPC/cholesterol (7:3) in 270 s. Each point is the average of 3 
trials (error bars represent the standard deviation). 
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7.7 U-tube experiments 
Source phase: 489 mM NaCl buffered to pH 7.2 with 5 mM sodium phosphate salts, 10 
mL. 
Receiver phase: 489 mM NaNO3 buffered to pH 7.2 with 5 mM sodium phosphate salts, 
10 mL. 
Organic phase: 2 mM tetrabutylammonium hexafluorophosphate in nitrobenzene with 1 
mM receptor 6 or 8 (no receptor was added for blank run), 20 mL. 
The organic phase was stirred gently at room temperature, and the chloride concentration 
of the receiver phase was determined using a chloride sensitive electrode (Accumet) after 
0 days, 2 days and 7 days. 
 
Fig. S61 The change in chloride concentration of the receiver phase of a U-tube 
apparatus mediated by receptors 6 and 8 (1 mM) compared to a control experiment with 
no receptor added. 
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8 Chloride 1H NMR titration stack plots 
NMR titrations were performed by addition of aliquots of the putative anionic guest as 
the tetrabutylammonium (0.15 M), in a solution of the receptor (0.01 M) in DMSO- 
d6/0.5% H2O, to a 0.01 M solution of the receptor in DMSO- d60.5% H2O. Both salt and 
receptor were dried under high vacuum prior to use. 1H NMR spectra were recorded on a 
Bruker AV300 or AV400 spectrometer and calibrated to the residual solvent peak in 
DMSO-d6 (δ = 2.50 ppm). 
 
Fig. S62 Stack plot showing the titration of receptor 5 with tetrabutylammonium chloride 
in DMSO-d6/ H2O 0.5 % at 298 K. 
 
Fig. S63 Stack plot showing the titration of receptor 5 with tetrabutylammonium chloride 
in DMSO-d6/ H2O 0.5 % at 323 K. 
 57 
 
Fig. S64 Stack plot showing the titration of receptor 5 with tetrabutylammonium chloride 
in CDCl3 at 298 K. 
 
Fig. S65 Stack plot showing the titration of receptor 5 with tetrabutylammonium chloride 
in CDCl3 at 323 K. 
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Fig. S66 Stack plot showing the titration of receptor 6 with tetrabutylammonium chloride 
in DMSO-d6/ H2O 0.5 % at 298 K. 
 
Fig. S67 Stack plot showing the titration of receptor 6 with tetrabutylammonium chloride 
in CDCl3 at 298 K. 
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Fig. S68 Stack plot showing the titration of receptor 7 with tetrabutylammonium chloride 
in DMSO-d6/ H2O 0.5 % at 298 K. 
 
Fig. S69 Stack plot showing the titration of receptor 7 with tetrabutylammonium chloride 
in CDCl3 at 298 K. 
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Fig. S70 Stack plot showing the titration of receptor 8 with tetrabutylammonium chloride 
in DMSO-d6/ H2O 0.5 % at 298 K. 
 
Fig. S71 Stack plot showing the titration of receptor 8 with tetrabutylammonium chloride 
in CDCl3 at 298 K. 
 61 
 
Fig. S72 Stack plot showing the titration of receptor 9 with tetrabutylammonium chloride 
in DMSO-d6/ H2O 0.5 % at 298 K. 
 
Fig. S73 Stack plot showing the titration of receptor 9 with tetrabutylammonium chloride 
in CDCl3 at 298 K. 
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Fig. S74 Stack plot showing the titration of receptor 10 with tetrabutylammonium 
chloride in DMSO-d6/ H2O 0.5 % at 298 K. 
 
Fig. S75 Stack plot showing the titration of receptor 10 with tetrabutylammonium 
chloride in CDCl3 at 298 K. 
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Fig. S76 Stack plot showing the titration of receptor 11 with tetrabutylammonium 
chloride in DMSO-d6/ H2O 0.5 % at 298 K. 
 
Fig. S77 Stack plot showing the titration of receptor 11 with tetrabutylammonium 
chloride in CDCl3 at 298 K. 
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9 HPLC experiments 
In order to assess the relative lipophilicity of the receptors studied, we utilised a 
previously reported HPLC experiment using a reverse phase column, as the retention 
time on the reverse phase column is related to its lipophilicity. The HPLC mobile phase 
was prepared with LC-MS grade methanol and water (Fisher Scientific UK, 
Loughborough, UK) containing 0.1% HCOOH each. Samples were prepared as a solution 
in LC-MS grade methanol at a concentration of 2 µg/mL. HPLC separations were 
performed on a Dionex Ultimate® 3000 UHPLC (Thermo Scientific, Hemel Hempstead, 
UK). Samples were injected (2 µL) directly onto a Kinetex C18 Column (50 mm X 2.1 
mm 1.7 µm particle size; Phenomenex, Torrance, CA, USA) thermostatically controlled 
at 40°C. The separation was achieved using 50% methanol in water for 2 minutes 
followed by a linear gradient to 100% methanol over 12 minutes and returned to 50 % 
methanol for 2 minutes at a flow rate of 0.3 mL/min. UV data were recorded at 254 nm 
and mass spectra were recorded using a Maxis™ ESI-ToF mass spectrometer (Bruker 
Daltonics, Bremen, Germany) using positive ion electrospray ionisation (120-1500 m/z) 
in order to assign to retention time to the respective receptor. 
The retention times of receptors 1-4 in a similar experiment have been previously 
reported. Good correlation was found between the previously reported values and those 
determined in this report (see below). 
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Fig. S78 Correlation between previously reported retention times for receptors 1-4 and 
those reported in this study 
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